Cancer_risk_after_iodine-131_therapy_for_hyperthyroidism._Cancer_incidence_was_studied_in_10,552_patients_(mean_age,_57_years)_who_received_131I_therapy_(mean_dose,_506_MBq)_for_hyperthyroidism_between_1950_and_1975._Follow-up_on_these_patients_was_continued_for_an_average_of_15_years._Record_linkage_with_the_Swedish_Cancer_Register_for_the_period_1958-1985_identified_1543_cancers_occurring_1_year_or_more_after_131I_treatment,_and_the_standardized_incidence_ratio_(SIR)_was_1.06_(95%_confidence_interval_=_1.01-1.11)._Significantly_increased_SIRs_were_observed_for_cancers_of_the_lung_(SIR_=_1.32;_n_=_105)_and_kidney_(SIR_=_1.39;_n_=_66)._Among_10-year_survivors,_significantly_elevated_risks_were_seen_for_cancers_of_the_stomach_(SIR_=_1.33;_n_=_58),_kidney_(SIR_=_1.51;_n_=_37),_and_brain_(SIR_=_1.63;_n_=_30)._Only_the_risk_for_stomach_cancer,_however,_increased_over_time_(P_less_than_.05)_and_with_increasing_activity_administered_(P_=_not_significant)._The_risk_for_malignant_lymphoma_was_significantly_below_expectation_(SIR_=_0.53;_n_=_11)._Overall_cancer_risk_did_not_increase_with_administered_131I_dose_or_with_time_since_exposure._The_absence_of_any_increase_in_leukemia_adds_further_support_to_the_view_that_a_radiation_dose_delivered_gradually_over_time_is_less_carcinogenic_than_the_same_total_dose_received_over_a_short_time._Only_for_stomach_cancer_was_a_possible_radiogenic_excess_suggested.